2 results
Approved WMOCompleted
The primary efficacy endpoint is treatment success in the therapy for mild to moderate Crohn*s disease with fisultas defined by: - A reduction of at least 50% in the number of draining fistulas at both week 4 and week 8
Approved WMOCompleted
The aim of the study is to compare an investigational injection system (Centargo) to the currently available Stellant CT injection system (with Multipatient disposable kit), in terms of efficiency, cost, performance, and user satisfaction (phase 1…